APA (7th ed.) Citation

Satapathy, S., Yadav, M. P., Ballal, S., Sahoo, R. K., & Bal, C. (2024). [177Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: A real-world study. European Journal of Nuclear Medicine & Molecular Imaging, 51(8), 2495. https://doi.org/10.1007/s00259-024-06677-y

Chicago Style (17th ed.) Citation

Satapathy, Swayamjeet, Madhav Prasad Yadav, Sanjana Ballal, Ranjit Kumar Sahoo, and Chandrasekhar Bal. "[177Lu]Lu-PSMA-617 as First-line Systemic Therapy in Patients with Metastatic Castration-resistant Prostate Cancer: A Real-world Study." European Journal of Nuclear Medicine & Molecular Imaging 51, no. 8 (2024): 2495. https://doi.org/10.1007/s00259-024-06677-y.

MLA (9th ed.) Citation

Satapathy, Swayamjeet, et al. "[177Lu]Lu-PSMA-617 as First-line Systemic Therapy in Patients with Metastatic Castration-resistant Prostate Cancer: A Real-world Study." European Journal of Nuclear Medicine & Molecular Imaging, vol. 51, no. 8, 2024, p. 2495, https://doi.org/10.1007/s00259-024-06677-y.